DEAD box 1 (DDX1) expression predicts for local control and overall survival in early stage, node-negative breast cancer

Dead-box or black-box: is DDX1 a potential biomarker in breast cancer?

(2010) Justin M. Balko et al.   BREAST CANCER RESEARCH AND TREATMENT

DEAD box 1: a novel and independent prognostic marker for early recurrence in breast cancer

(2010) Devon R. Germain et al.   BREAST CANCER RESEARCH AND TREATMENT

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Gain of MYCN Region in a Wilms Tumor-derived Xenotransplanted Cell Line

(2010) Rosa Noguera et al.   DIAGNOSTIC MOLECULAR PATHOLOGY

Molecular Subtyping of Early-Stage Breast Cancer: Implications for Radiation Therapy

(2010) Bruce G. Haffty et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Adjuvant Hormonal Therapy for Early-Stage Breast Cancer

(2010) Harold J. Burstein et al.   Surgical Oncology Clinics of North America

Role of biologic therapy and chemotherapy in hormone receptor- and HER2-positive breast cancer

(2009) A. U. Buzdar   ANNALS OF ONCOLOGY

Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays

(2009) Kathy S. Albain et al.   BREAST

Genomic and clinical analyses of 2p24 and 12q13-q14 amplification in alveolar rhabdomyosarcoma: A report from the Children's Oncology Group

(2009) Frederic G. Barr et al.   GENES CHROMOSOMES & CANCER

DDX1 is required for testicular tumorigenesis, partially through the transcriptional activation of 12p stem cell genes

(2009) K Tanaka et al.   ONCOGENE

A Role for DEAD Box 1 at DNA Double-Strand Breaks

(2008) L. Li et al.   MOLECULAR AND CELLULAR BIOLOGY